- $698.94m
- $776.48m
- BRL2.23bn
- 83
- 53
- 66
- 75
Annual income statement for Ci&T, fiscal year end - December 31st, BRL millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F |
| Standards: | — | USG | USG | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 1,444 | 2,188 | 2,233 |
| Cost of Revenue | ||||
| Gross Profit | — | 509 | 762 | 746 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | — | 1,200 | 1,914 | 1,948 |
| Operating Profit | 0 | 245 | 274 | 285 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | — | 210 | 200 | 209 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 0 | 126 | 95.7 | 133 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 0 | 126 | 95.7 | 133 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 0 | 126 | 95.7 | 133 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | — | 0.955 | 0.91 | 1.1 |